A Randomized Trial of Encorafenib and Cetuximab Versus Irinotecan/Cetuximab or FOLFIRI/Cetuximab in Chinese Patients With BRAF(V600E) Mutant Metastatic Colorectal Cancer: The NAUTICAL Study
一项针对BRAF(V600E)突变型转移性结直肠癌中国患者的随机试验:恩考拉非尼联合西妥昔单抗与伊立替康/西妥昔单抗或FOLFIRI/西妥昔单抗的比较研究:NAUTICAL研究
期刊:Cancer Medicine
影响因子:3.1
doi:10.1002/cam4.71697
Xicheng, Wang; Yanhong, Deng; Yanqiao, Zhang; Tianshu, Liu; Xianglin, Yuan; Jianwei, Yang; Tao, Zhang; Aimin, Zang; Yu, Liu; Li, Huang; Feng, Ye; Hong, Zong; Yi, Ba; Isabelle, Klauck; Jean-Claude, Vedovato; Mélanie, Groc; Angela, Guo; Jian, Li; Lin, Shen